BACKGROUND: Approximately 10% of sudden infant death syndrome (SIDS) cases may stem from potentially lethal cardiac channelopathies, with approximately half of channelopathic SIDS involving the Na(V)1.5 cardiac sodium channel. Recently, Na(V) beta subunits have been implicated in various cardiac arrhythmias. Thus, the 4 genes encoding Na(V) beta subunits represent plausible candidate genes for SIDS. OBJECTIVE: This study sought to determine the spectrum, prevalence, and functional consequences of sodium channel beta-subunit mutations in a SIDS cohort. METHODS: In this institutional review board-approved study, mutational analysis of the 4 beta-subunit genes, SCN1B to 4B, was performed using polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing of DNA derived from 292 SIDS cases. Engineered mutations were coexpressed with SCN5A in HEK 293 cells and were whole-cell patch clamped. One of the putative SIDS-associated mutations was similarly studied in adenovirally transduced adult rat ventricular myocytes. RESULTS: Three rare (absent in 200 to 800 reference alleles) missense mutations (beta3-V36M, beta3-V54G, and beta4-S206L) were identified in 3 of 292 SIDS cases. Compared with SCN5A+beta3-WT, beta3-V36M significantly decreased peak I(Na) and increased late I(Na), whereas beta3-V54G resulted in a marked loss of function. beta4-S206L accentuated late I(Na) and positively shifted the midpoint of inactivation compared with SCN5A+beta4-WT. In native cardiomyocytes, beta4-S206L accentuated late I(Na) and increased the ventricular action potential duration compared with beta4-WT. CONCLUSION: This study provides the first molecular and functional evidence to implicate the Na(V) beta subunits in SIDS pathogenesis. Altered Na(V)1.5 sodium channel function due to beta-subunit mutations may account for the molecular pathogenic mechanism underlying approximately 1% of SIDS cases. Copyright (c) 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
BACKGROUND: Approximately 10% of sudden infant death syndrome (SIDS) cases may stem from potentially lethal cardiac channelopathies, with approximately half of channelopathic SIDS involving the Na(V)1.5 cardiac sodium channel. Recently, Na(V) beta subunits have been implicated in various cardiac arrhythmias. Thus, the 4 genes encoding Na(V) beta subunits represent plausible candidate genes for SIDS. OBJECTIVE: This study sought to determine the spectrum, prevalence, and functional consequences of sodium channel beta-subunit mutations in a SIDS cohort. METHODS: In this institutional review board-approved study, mutational analysis of the 4 beta-subunit genes, SCN1B to 4B, was performed using polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing of DNA derived from 292 SIDS cases. Engineered mutations were coexpressed with SCN5A in HEK 293 cells and were whole-cell patch clamped. One of the putative SIDS-associated mutations was similarly studied in adenovirally transduced adult rat ventricular myocytes. RESULTS: Three rare (absent in 200 to 800 reference alleles) missense mutations (beta3-V36M, beta3-V54G, and beta4-S206L) were identified in 3 of 292 SIDS cases. Compared with SCN5A+beta3-WT, beta3-V36M significantly decreased peak I(Na) and increased late I(Na), whereas beta3-V54G resulted in a marked loss of function. beta4-S206L accentuated late I(Na) and positively shifted the midpoint of inactivation compared with SCN5A+beta4-WT. In native cardiomyocytes, beta4-S206L accentuated late I(Na) and increased the ventricular action potential duration compared with beta4-WT. CONCLUSION: This study provides the first molecular and functional evidence to implicate the Na(V) beta subunits in SIDS pathogenesis. Altered Na(V)1.5sodium channel function due to beta-subunit mutations may account for the molecular pathogenic mechanism underlying approximately 1% of SIDS cases. Copyright (c) 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Authors: Bi-Hua Tan; Carmen R Valdivia; Benjamin A Rok; Bin Ye; Karen M Ruwaldt; David J Tester; Michael J Ackerman; Jonathan C Makielski Journal: Heart Rhythm Date: 2005-07 Impact factor: 6.343
Authors: P J Schwartz; M Stramba-Badiale; A Segantini; P Austoni; G Bosi; R Giorgetti; F Grancini; E D Marni; F Perticone; D Rosti; P Salice Journal: N Engl J Med Date: 1998-06-11 Impact factor: 91.245
Authors: Henry F Krous; J Bruce Beckwith; Roger W Byard; Torleiv O Rognum; Thomas Bajanowski; Tracey Corey; Ernest Cutz; Randy Hanzlick; Thomas G Keens; Edwin A Mitchell Journal: Pediatrics Date: 2004-07 Impact factor: 7.124
Authors: Q Wang; J Shen; I Splawski; D Atkinson; Z Li; J L Robinson; A J Moss; J A Towbin; M T Keating Journal: Cell Date: 1995-03-10 Impact factor: 41.582
Authors: Peter J Mohler; Ilaria Rivolta; Carlo Napolitano; Guy LeMaillet; Stephen Lambert; Silvia G Priori; Vann Bennett Journal: Proc Natl Acad Sci U S A Date: 2004-12-03 Impact factor: 11.205
Authors: Jianding Cheng; Carmen R Valdivia; Ravi Vaidyanathan; Ravi C Balijepalli; Michael J Ackerman; Jonathan C Makielski Journal: J Mol Cell Cardiol Date: 2013-03-26 Impact factor: 5.000
Authors: Dan Hu; Hector Barajas-Martínez; Argelia Medeiros-Domingo; Lia Crotti; Christian Veltmann; Rainer Schimpf; Janire Urrutia; Aintzane Alday; Oscar Casis; Ryan Pfeiffer; Elena Burashnikov; Gabriel Caceres; David J Tester; Christian Wolpert; Martin Borggrefe; Peter Schwartz; Michael J Ackerman; Charles Antzelevitch Journal: Heart Rhythm Date: 2011-12-07 Impact factor: 6.343
Authors: Rou-Mu Hu; Bi-Hua Tan; Kate M Orland; Carmen R Valdivia; Amber Peterson; Jielin Pu; Jonathan C Makielski Journal: Am J Physiol Heart Circ Physiol Date: 2013-02-01 Impact factor: 4.733